$RXO
RXO, Inc.

2023 Q3 Form 10-Q Financial Statement

#000192956123000074 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $976.0M $963.0M $1.226B
YoY Change -14.24% -21.45% 11.56%
Cost Of Revenue $801.0M $782.0M $960.0M
YoY Change -12.27% -18.54% 5.73%
Gross Profit $175.0M $181.0M $266.0M
YoY Change -22.22% -31.95% 39.27%
Gross Profit Margin 17.93% 18.8% 21.7%
Selling, General & Admin $148.0M $144.0M $166.0M
YoY Change -6.33% -13.25% 33.87%
% of Gross Profit 84.57% 79.56% 62.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $16.00M $18.00M $21.00M
YoY Change -30.43% -14.29% 5.0%
% of Gross Profit 9.14% 9.94% 7.89%
Operating Expenses $148.0M $162.0M $187.0M
YoY Change -6.33% -13.37% 29.86%
Operating Profit $6.000M $19.00M $79.00M
YoY Change -60.0% -75.95% 68.09%
Interest Expense -$8.000M -$8.000M $0.00
YoY Change -900.0%
% of Operating Profit -133.33% -42.11% 0.0%
Other Income/Expense, Net -$1.000M $0.00 $1.000M
YoY Change 0.0% -100.0% 0.0%
Pretax Income -$3.000M $6.000M $59.00M
YoY Change -120.0% -89.83% 22.92%
Income Tax -$2.000M $3.000M $15.00M
% Of Pretax Income 50.0% 25.42%
Net Earnings -$1.000M $3.000M $44.00M
YoY Change -107.69% -93.18% 25.71%
Net Earnings / Revenue -0.1% 0.31% 3.59%
Basic Earnings Per Share -$0.01 $0.03 $0.38
Diluted Earnings Per Share -$0.01 $0.03 $0.38
COMMON SHARES
Basic Shares Outstanding 117.0M shares 116.9M shares 115.2M shares
Diluted Shares Outstanding 117.0M shares 119.5M shares 115.2M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.0M $124.0M $212.0M
YoY Change -44.39% -41.51%
Cash & Equivalents $104.0M $124.0M $212.0M
Short-Term Investments
Other Short-Term Assets $45.00M $49.00M $32.00M
YoY Change 73.08% 53.13%
Inventory
Prepaid Expenses
Receivables $787.0M $743.0M $1.107B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $936.0M $916.0M $1.351B
YoY Change -23.59% -32.2%
LONG-TERM ASSETS
Property, Plant & Equipment $295.0M $280.0M $284.0M
YoY Change 4.98% -1.41%
Goodwill $630.0M $630.0M
YoY Change 0.0%
Intangibles $72.00M $73.00M
YoY Change -15.29%
Long-Term Investments
YoY Change
Other Assets $13.00M $13.00M $17.00M
YoY Change -18.75% -23.53%
Total Long-Term Assets $1.010B $996.0M $1.021B
YoY Change -0.2% -2.45%
TOTAL ASSETS
Total Short-Term Assets $936.0M $916.0M $1.351B
Total Long-Term Assets $1.010B $996.0M $1.021B
Total Assets $1.946B $1.912B $2.372B
YoY Change -13.01% -19.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $448.0M $432.0M $615.0M
YoY Change -18.1% -29.76%
Accrued Expenses $221.0M $258.0M $338.0M
YoY Change -22.18% -23.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.000M $4.000M
YoY Change -40.0%
Total Short-Term Liabilities $728.0M $699.0M $957.0M
YoY Change -18.02% -26.96%
LONG-TERM LIABILITIES
Long-Term Debt $451.0M $451.0M $0.00
YoY Change 7416.67%
Other Long-Term Liabilities $37.00M $156.0M $165.0M
YoY Change 2.78% -5.45%
Total Long-Term Liabilities $628.0M $607.0M $165.0M
YoY Change 206.34% 267.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $728.0M $699.0M $957.0M
Total Long-Term Liabilities $628.0M $607.0M $165.0M
Total Liabilities $1.356B $1.323B $1.173B
YoY Change 24.06% 12.79%
SHAREHOLDERS EQUITY
Retained Earnings $4.000M $5.000M
YoY Change
Common Stock $1.000M $1.000M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $590.0M $589.0M $1.199B
YoY Change
Total Liabilities & Shareholders Equity $1.946B $1.912B $2.372B
YoY Change -13.01% -19.39%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.000M $3.000M $44.00M
YoY Change -107.69% -93.18% 25.71%
Depreciation, Depletion And Amortization $16.00M $18.00M $21.00M
YoY Change -30.43% -14.29% 5.0%
Cash From Operating Activities $4.000M $24.00M $74.00M
YoY Change -92.98% -67.57% -11.9%
INVESTING ACTIVITIES
Capital Expenditures $18.00M $16.00M $12.00M
YoY Change 20.0% 33.33% 20.0%
Acquisitions
YoY Change
Other Investing Activities -$1.000M $0.00
YoY Change -200.0% -100.0%
Cash From Investing Activities -$19.00M -$16.00M -$12.00M
YoY Change 35.71% 33.33% 33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.000M -5.000M 104.0M
YoY Change -94.12% -104.81% -201.96%
NET CHANGE
Cash From Operating Activities 4.000M 24.00M 74.00M
Cash From Investing Activities -19.00M -16.00M -12.00M
Cash From Financing Activities -4.000M -5.000M 104.0M
Net Change In Cash -19.00M 3.000M 166.0M
YoY Change -24.0% -98.19% -714.81%
FREE CASH FLOW
Cash From Operating Activities $4.000M $24.00M $74.00M
Capital Expenditures $18.00M $16.00M $12.00M
Free Cash Flow -$14.00M $8.000M $62.00M
YoY Change -133.33% -87.1% -16.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
116400000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
116400000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
0 usd
rxo Payments To Proceeds From Parent Financing Activities
PaymentsToProceedsFromParentFinancingActivities
-30000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
36000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
21000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
6000000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
201000 shares
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3000000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
11000000 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
654000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
589000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1043000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
44000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000000 usd
CY2022Q2 rxo Net Transfers To Parent
NetTransfersToParent
-110000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1070000000 usd
us-gaap Net Income Loss
NetIncomeLoss
83000000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
6000000 usd
rxo Net Transfers To Parent
NetTransfersToParent
-40000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1199000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportingsegment
CY2022Q4 rxo Stockholders Equity Note Spinoff Transaction Percent Of Shares Outstanding Distributed
StockholdersEquityNoteSpinoffTransactionPercentOfSharesOutstandingDistributed
1
CY2022Q4 rxo Shares Of Companys Common Stock
SharesOfCompanysCommonStock
1 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2538000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2538000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
136000000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.99
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
3000000 usd
us-gaap Restructuring Charges
RestructuringCharges
9000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
7000000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
463000000 usd
CY2023Q2 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
455000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
464000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
455000000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q2 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
4000000 usd
CY2023Q2 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
459000000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2022Q4 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
460000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
451000000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
44000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
83000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
83000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116894000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116748000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
115163000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2563000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2666000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119457000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119414000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115163000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares

Files In Submission

Name View Source Status
0001929561-23-000074-index-headers.html Edgar Link pending
0001929561-23-000074-index.html Edgar Link pending
0001929561-23-000074.txt Edgar Link pending
0001929561-23-000074-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rxo-20230630.htm Edgar Link pending
rxo-20230630.xsd Edgar Link pending
rxo-20230630_g1.jpg Edgar Link pending
rxo2023q210-qexx311.htm Edgar Link pending
rxo2023q210-qexx312.htm Edgar Link pending
rxo2023q210-qexx321.htm Edgar Link pending
rxo2023q210-qexx322.htm Edgar Link pending
Show.js Edgar Link pending
rxo-20230630_def.xml Edgar Link unprocessable
rxo-20230630_lab.xml Edgar Link unprocessable
rxo-20230630_pre.xml Edgar Link unprocessable
rxo-20230630_cal.xml Edgar Link unprocessable
rxo-20230630_htm.xml Edgar Link completed